Nationwide Case Review
Call 24/7 1-800-883-9858

  • Drugs Recalls
  • Devices and Implants
  • FDA Alerts
  • About Us
  • Español
  • Contact Us
Nationwide Case Review
Call 24/7 1-800-883-9858

  • Drugs Recalls
  • Devices and Implants
  • FDA Alerts
  • About Us
  • Español
  • Contact Us
Nationwide Case Review
Call 24/7 1-800-883-9858

  • Drugs Recalls
  • Devices and Implants
  • FDA Alerts
  • About Us
  • Español
  • Contact Us

Zantac

  • Home
  • Drugs
  • Zantac
Published by admin on August 28, 2020
Categories
  • Drugs
Tags

Department of Justice Probes Zantac Manufacturers on Potential Fraud Charges

Zantac Lawsuits are being filed nationwide by thousands of people who have taken Zantac or generic Ranitidine and later were diagnosed with cancer after being exposed to high levels of the carcinogen, NDMA. Now, the Justice Department wants answers from Zantac Manufacturers GlaxoSmithKline (GSK) and Sanofi. Plaintiffs in the civil suits against GSK and Sanofi claim the companies failed to disclose the presence of N-nitrosodimethylamine (NDMA). According to Reuters, Sanofi and GSK both received “civil investigation demands from the Justice Department last month seeking information related to Zantac.”

Zantac Manufacturers Knew the Risks Associated with NDMA in Ranitidine

After the U.S. Food and Drug Administration (FDA) requested Zantac manufacturers recall Zantac and Ranitidine products on April 1, 2020, the DOJ began looking into claims that the pharmaceutical giants that produce ranitidine were failing to disclose to the public and other healthcare providers that Zantac and ranitidine contained NDMA at levels that vastly exceeded the FDA’s daily acceptable intake limit.

Over the past year, thousands of plaintiffs allege both companies failed to warn them and the public of the risks associated with NDMA contained in their medications. Numerous clinical and public studies conducted from the 1980’s through 2020 almost always confirmed the presence of NDMA in ranitidine but the drug manufacturers studies never list it as a substance in their test results and trials.

Zantac Litigation Update

Zantac lawsuits that are in federal court are now part of a multi-district litigation located in the Southern District of Florida in the United States District Court. The defendants in this mass tort are Sanofi, GlaxoSmithKline, Boehringer Ingelheim, and other Zantac manufacturers. There are currently thousands of cases being sorted through by the District Court. To better organize the order of the case proceedings and to reduce case expenses for firms and clients, the court has ordered a Zantac census be conducted for individuals who have filed Zantac claims.

The Zantac MDL is now open for discovery in the litigation procedure. Judge Rosenberg who is handling the litigation has indicated discovery will last for around 18 months and should be complete by December of 2021. The Zantac MDL has the potential to become a multi-billion-dollar lawsuit if the FDA’s cancer rate estimates on users of Zantac are correct.

FDA Zantac Recall

Valisure Pharmacy is how it all began. In June 2019, the online pharmacy that conducts research on consumer drugs to verify they are chemically sound and safe for consumers released its findings that NDMA was present in all the samples of Zantac and ranitidine tested. In the citizen’s petition sent to the FDA, Valisure urged the FDA to recall all Zantac and Ranitidine products immediately.

The FDA began conducting their own tests which did find some products contained NDMA but it wasn’t until further test results were released confirming the instability of the ranitidine molecule, that the FDA issued a Zantac and ranitidine recall in April of 2020. By that point, thousands of people who took the drug for years and later were diagnosed with cancer had filed lawsuits against the manufacturers.

Financial Compensation for Zantac

If you or your loved ones took Zantac and later were diagnosed with a Zantac cancer or ranitidine cancer, you may be entitled to a Zantac lawsuit against the manufacturers. The makers of Zantac and ranitidine failed to disclose the harmful substances hidden in their medication. They may have known for decades about the dangers of the NDMA present in their medicine and failed to warn consumers about the known dangers. Contact the Drug Attorneys at the Willis Law Firm for a free and confidential Zantac Cancer case evaluation. By calling us or submitting the form on this page, we can quickly determine whether or not you may be entitled to significant financial compensation for your drug injuries. Contact us today!

Share
admin

Review My Case

Free & Confidential Consultation

    board-certified-lawyer

    Attorney David P. Willis is a nationally recognized Trial Lawyer with more than 37 years of fighting for his clients' rights. Mr. Willis is a former Briefing Attorney for the Supreme Court of Texas and he is Board Certified in Personal Injury Trial Law since 1988.

    attorney-david-willis

    "Through his many years of dedication and service to his clients, David Willis has been successful in forcing many billion dollar corporations to make major safety changes to their products and the ways they conduct business."

    Willis-Law-Firm-awards
    Willis-Law-Firm-awards

    willis logo white

    Principle Office Location
    5005 Riverway Drive
    Suite 160
    Houston, TX 77056
    Call 24/7 1-800-883-9858

    THIS IS ATTORNEY ADVERTISING

    Contact Us Español About Us Notices & Disclaimer Privacy Policy

    © 2006-2020 Willis Law Firm. All Rights Reserved. Sitemap